{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:37:54Z","timestamp":1770928674547,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103488","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:53:32Z","timestamp":1770926012000},"source":"Crossref","is-referenced-by-count":0,"title":["Whole-Food Dietary Interventions in Crohn\u2019s Disease: A Literature Review"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Al-Majmuei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Fakhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyaba","family":"Imran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor B","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011, 474:307-17. 10.1038\/nature10209","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.019","article-title":"Diet as a trigger or therapy for inflammatory bowel diseases","volume":"152","author":"Lewis JD","year":"2017","unstructured":"Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017, 152:398-414.e6. 10.1053\/j.gastro.2016.10.019","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan GG","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021, 18:56-66. 10.1038\/s41575-020-00360-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000195385.19268.68","article-title":"Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities","volume":"12 Suppl 1","author":"Hanauer SB","year":"2006","unstructured":"Hanauer SB. Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006, 12 Suppl 1:S3-9. 10.1097\/01.mib.0000195385.19268.68","journal-title":"Inflamm Bowel Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle A","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020, 17:223-37. 10.1038\/s41575-019-0258-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu10030365","article-title":"The Western diet-microbiome-host interaction and its role in metabolic disease","volume":"10","author":"Zin\u00f6cker MK","year":"2018","unstructured":"Zin\u00f6cker MK, Lindseth IA. The Western diet-microbiome-host interaction and its role in metabolic disease. Nutrients. 2018, 10:365. 10.3390\/nu10030365","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.036","article-title":"Food, immunity, and the microbiome","volume":"148","author":"Tilg H","year":"2015","unstructured":"Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology. 2015, 148:1107-19. 10.1053\/j.gastro.2014.12.036","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.041","article-title":"How do we measure academic strength in gastroenterology and hepatology divisions, beyond hospital rankings?","volume":"156","author":"Skef W","year":"2019","unstructured":"Skef W, Xia Y, Staudacher JJ, Jung B. How do we measure academic strength in gastroenterology and hepatology divisions, beyond hospital rankings?. Gastroenterology. 2019, 156:4-6. 10.1053\/j.gastro.2018.11.041","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200007000-00002","article-title":"The next molecule of the year?: Carbon monoxide as a regulator of host inflammatory responses","volume":"31","author":"Tepperman B","year":"2000","unstructured":"Tepperman B. The next molecule of the year?: Carbon monoxide as a regulator of host inflammatory responses. J Pediatr Gastroenterol Nutr. 2000, 31:2. 10.1097\/00005176-200007000-00002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001896","article-title":"Nutrition in pediatric inflammatory bowel disease: A position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"Miele E","year":"2018","unstructured":"Miele E, Shamir R, Aloi M, et al.. Nutrition in pediatric inflammatory bowel disease: A position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018, 66:687-708. 10.1097\/MPG.0000000000001896","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315866","article-title":"Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases","volume":"67","author":"Levine A","year":"2018","unstructured":"Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018, 67:1726-38. 10.1136\/gutjnl-2017-315866","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.05.047","article-title":"A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn's disease","volume":"161","author":"Lewis JD","year":"2021","unstructured":"Lewis JD, Sandler RS, Brotherton C, et al.. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn's disease. Gastroenterology. 2021, 161:837-852.e9. 10.1053\/j.gastro.2021.05.047","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012839.pub2","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","volume":"2","author":"Limketkai BN","year":"2019","unstructured":"Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, et al.. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev. 2019, 2:CD012839. 10.1002\/14651858.CD012839.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03315-7","article-title":"The effect of solid food diet therapies on the induction and maintenance of remission in Crohn's disease: A systematic review","volume":"24","author":"Zhang JL","year":"2024","unstructured":"Zhang JL, Vootukuru N, Niewiadomski O. The effect of solid food diet therapies on the induction and maintenance of remission in Crohn's disease: A systematic review. BMC Gastroenterol. 2024, 24:250. 10.1186\/s12876-024-03315-7","journal-title":"BMC Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.12.004","article-title":"ESPEN guideline on clinical nutrition in inflammatory bowel disease","volume":"42","author":"Bischoff SC","year":"2023","unstructured":"Bischoff SC, Bager P, Escher J, et al.. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr. 2023, 42:352-79. 10.1016\/j.clnu.2022.12.004","journal-title":"Clin Nutr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194003","article-title":"Dietary patterns and gut microbiota changes in inflammatory bowel disease: Current insights and future challenges","volume":"14","author":"Yan J","year":"2022","unstructured":"Yan J, Wang L, Gu Y, Hou H, Liu T, Ding Y, Cao H. Dietary patterns and gut microbiota changes in inflammatory bowel disease: Current insights and future challenges. Nutrients. 2022, 14:4003. 10.3390\/nu14194003","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.70106","article-title":"Effects of a low FODMAP diet in inflammatory bowel disease and patient experiences: A mixed methods systematic literature review and meta-analysis","volume":"38","author":"Ville A","year":"2025","unstructured":"Ville A, McRae R, Nomchong J, Reidlinger DP, Davidson AR, Staudacher HM, Albarqouni L. Effects of a low FODMAP diet in inflammatory bowel disease and patient experiences: A mixed methods systematic literature review and meta-analysis. J Hum Nutr Diet. 2025, 38:e70106. 10.1111\/jhn.70106","journal-title":"J Hum Nutr Diet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i22.6809","article-title":"Exclusive enteral nutrition in children with Crohn's disease","volume":"21","author":"Day AS","year":"2015","unstructured":"Day AS, Lopez RN. Exclusive enteral nutrition in children with Crohn's disease. World J Gastroenterol. 2015, 21:6809-16. 10.3748\/wjg.v21.i22.6809","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318235b397","article-title":"Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease","volume":"54","author":"Critch J","year":"2012","unstructured":"Critch J, Day AS, Otley A, King-Moore C, Teitelbaum JE, Shashidhar H. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012, 54:298-305. 10.1097\/MPG.0b013e318235b397","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7652","article-title":"Use of exclusive enteral nutrition in adults with Crohn's disease: A review","volume":"19","author":"Wall CL","year":"2013","unstructured":"Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn's disease: A review. World J Gastroenterol. 2013, 19:7652-60. 10.3748\/wjg.v19.i43.7652","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000200323.38139.c6","article-title":"Specificities of the fecal microbiota in inflammatory bowel disease","volume":"12","author":"Sokol H","year":"2006","unstructured":"Sokol H, Seksik P, Rigottier-Gois L, et al.. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12:106-11. 10.1097\/01.MIB.0000200323.38139.c6","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2014.21","article-title":"Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease","volume":"6","author":"Kaakoush NO","year":"2015","unstructured":"Kaakoush NO, Day AS, Leach ST, Lemberg DA, Nielsen S, Mitchell HM. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease. Clin Transl Gastroenterol. 2015, 6:e71. 10.1038\/ctg.2014.21","journal-title":"Clin Transl Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2017.09.007","article-title":"Nutritional interventions in the patient with inflammatory bowel disease","volume":"47","author":"Limketkai BN","year":"2018","unstructured":"Limketkai BN, Wolf A, Parian AM. Nutritional interventions in the patient with inflammatory bowel disease. Gastroenterol Clin North Am. 2018, 47:155-77. 10.1016\/j.gtc.2017.09.007","journal-title":"Gastroenterol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04065.x","article-title":"Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C","volume":"30","author":"Breilh D","year":"2009","unstructured":"Breilh D, Foucher J, Cast\u00e9ra L, et al.. Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C. Aliment Pharmacol Ther. 2009, 30:487-94. 10.1111\/j.1365-2036.2009.04065.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.002","article-title":"Treatment of active Crohn's disease with an ordinary food-based diet that replicates exclusive enteral nutrition","volume":"156","author":"Svolos V","year":"2019","unstructured":"Svolos V, Hansen R, Nichols B, et al.. Treatment of active Crohn's disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology. 2019, 156:1354-1367.e6. 10.1053\/j.gastro.2018.12.002","journal-title":"Gastroenterology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00299-5","article-title":"The Crohn\u2019s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn\u2019s disease (CDED-AD): An open-label, pilot, randomised trial","volume":"7","author":"Yanai H","year":"2022","unstructured":"Yanai H, Levine A, Hirsch A, et al.. The Crohn\u2019s disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn\u2019s disease (CDED-AD): An open-label, pilot, randomised trial. Lancet Gastroenterol Hepatol. 2022, 7:49-59. 10.1016\/S2468-1253(21)00299-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000841","article-title":"Crohn's disease therapeutic dietary intervention (CD-TDI): Study protocol for a randomised controlled trial","volume":"9","author":"Raman M","year":"2022","unstructured":"Raman M, Ma C, Taylor LM, et al.. Crohn's disease therapeutic dietary intervention (CD-TDI): Study protocol for a randomised controlled trial. BMJ Open Gastroenterol. 2022, 9:e000841. 10.1136\/bmjgast-2021-000841","journal-title":"BMJ Open Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx071","article-title":"Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy","volume":"11","author":"Sigall Boneh R","year":"2017","unstructured":"Sigall Boneh R, Sarbagili Shabat C, Yanai H, Chermesh I, Ben Avraham S, Boaz M, Levine A. Dietary therapy with the Crohn's disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy. J Crohns Colitis. 2017, 11:1205-12. 10.1093\/ecco-jcc\/jjx071","journal-title":"J Crohns Colitis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/17562848251323553","article-title":"Patient experiences with and adherence to Crohn\u2019s disease exclusion diet in Dutch Crohn\u2019s disease patients: A cohort study","volume":"18","author":"Wijers FTR","year":"2025","unstructured":"Wijers FTR, van Zundert SMC, Verburgt CM, van der Kruk N, Van Limbergen JE, Wierdsma NJ. Patient experiences with and adherence to Crohn\u2019s disease exclusion diet in Dutch Crohn\u2019s disease patients: A cohort study. Therap Adv Gastroenterol. 2025, 18:17562848251323553. 10.1177\/17562848251323553","journal-title":"Therap Adv Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313099","article-title":"Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation","volume":"66","author":"Chassaing B","year":"2017","unstructured":"Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017, 66:1414-27. 10.1136\/gutjnl-2016-313099","journal-title":"Gut"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052132","article-title":"Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin","volume":"7","author":"Nickerson KP","year":"2012","unstructured":"Nickerson KP, McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One. 2012, 7:e52132. 10.1371\/journal.pone.0052132","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.11.018","article-title":"The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease","volume":"42","author":"Lv Y","year":"2023","unstructured":"Lv Y, Lou Y, Liu A, et al.. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease. Clin Nutr. 2023, 42:116-28. 10.1016\/j.clnu.2022.11.018","journal-title":"Clin Nutr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4307-y","article-title":"Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease","volume":"61","author":"Suskind DL","year":"2016","unstructured":"Suskind DL, Wahbeh G, Cohen SA, et al.. Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease. Dig Dis Sci. 2016, 61:3255-60. 10.1007\/s10620-016-4307-y","journal-title":"Dig Dis Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/nu7115459","article-title":"Definition of the Mediterranean diet; A literature review","volume":"7","author":"Davis C","year":"2015","unstructured":"Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet; A literature review. Nutrients. 2015, 7:9139-53. 10.3390\/nu7115459","journal-title":"Nutrients"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000001024","article-title":"An update on dietary therapies in paediatric Crohn's disease","volume":"27","author":"Gkikas K","year":"2024","unstructured":"Gkikas K, Svolos V, White B, Gerasimidis K. An update on dietary therapies in paediatric Crohn's disease. Curr Opin Clin Nutr Metab Care. 2024, 27:304-12. 10.1097\/MCO.0000000000001024","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000708","article-title":"Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease","volume":"22","author":"Prince AC","year":"2016","unstructured":"Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016, 22:1129-36. 10.1097\/MIB.0000000000000708","journal-title":"Inflamm Bowel Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123648","article-title":"Low FODMAP diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: A systematic review of randomized controlled trials","volume":"12","author":"Grammatikopoulou MG","year":"2020","unstructured":"Grammatikopoulou MG, Goulis DG, Gkiouras K, et al.. Low FODMAP diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: A systematic review of randomized controlled trials. Nutrients. 2020, 12:3648. 10.3390\/nu12123648","journal-title":"Nutrients"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200303000-00004","article-title":"Pulmonary manifestations of inflammatory bowel disease","volume":"9","author":"Storch I","year":"2003","unstructured":"Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2003, 9:104-15. 10.1097\/00054725-200303000-00004","journal-title":"Inflamm Bowel Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000437984.92565.31","article-title":"Fiber in the treatment and maintenance of inflammatory bowel disease: A systematic review of randomized controlled trials","volume":"20","author":"Wedlake L","year":"2014","unstructured":"Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: A systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014, 20:576-86. 10.1097\/01.MIB.0000437984.92565.31","journal-title":"Inflamm Bowel Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03431.x","article-title":"Meta-analysis: Enteral nutrition in active Crohn's disease in children","volume":"26","author":"Dziechciarz P","year":"2007","unstructured":"Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: Enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther. 2007, 26:795-806. 10.1111\/j.1365-2036.2007.03431.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing B","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015, 519:92-6. 10.1038\/nature14232","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.09.008","article-title":"Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease","volume":"18","author":"Lewis JD","year":"2015","unstructured":"Lewis JD, Chen EZ, Baldassano RN, et al.. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015, 18:489-500. 10.1016\/j.chom.2015.09.008","journal-title":"Cell Host Microbe"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-6-883","article-title":"Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor","volume":"105","author":"Hollander D","year":"1986","unstructured":"Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986, 105:883-5. 10.7326\/0003-4819-105-6-883","journal-title":"Ann Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner JR","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009, 9:799-809. 10.1038\/nri2653","journal-title":"Nat Rev Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: Medical treatment","volume":"14","author":"Torres J","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, et al.. ECCO guidelines on therapeutics in Crohn's disease: Medical treatment. J Crohns Colitis. 2020, 14:4-22. 10.1093\/ecco-jcc\/jjz180","journal-title":"J Crohns Colitis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/461339-whole-food-dietary-interventions-in-crohns-disease-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:53:32Z","timestamp":1770926012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/461339-whole-food-dietary-interventions-in-crohns-disease-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.103488","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}